Molecular Templates, Inc. revenue for the last year amounted to 57.31 M USD, the most of which — 52.62 M USD — came from its highest performing source at the moment, Biologic Therapeutics for Cancer, the year earlier bringing 19.75 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Molecular Templates, Inc. 52.62 M USD, and the year before that — 17.17 M USD.